Society Letters

Title X Make It Right Endorsement Memo

March 30, 2021

To Biden-Harris Administration:

"The timeline recently outlined by HHS for finalizing that rulemaking by the fall and issuing a funding announcement in December 2021 will mean that current and former Title X entities will largely see no relief from the Trump rule until mid 2022. For family planning and sexual health provider networks already devastated by the impact of the Trump rule and also facing a global pandemic, this is simply not soon enough. We urge the Biden-Harris administration to continue moving this process forward with the urgency warranted by the situation and take all necessary actions to offer relief in 2021."

arrowRead the Full Letter

Last Updated:
Take Action

Make Your Voice Heard

We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.